Laboratory Products
Cell Culture Medium for Clinical Research
Sep 26 2018
Amsbio announces the launch of StemFit® Basic03 clinical grade stem cell culture for regenerative medicine.
Provided as a animal-origin free, ready to use media for cell therapy applications, StemFit® AK03N which is the Japanese version of Basic03 has already been accepted by Pharmaceuticals and Medical Devices Agency, Japan (PMDA) for retinal regenerative medicine clinical trials using human induced pluripotent stem cells (hiPSCs).
In an independent study, media of different formulations were compared with StemFit® Basic03 for culturing iPS cells. The resultant research data showed, iPS cells cultured with StemFit® Basic03 offered higher cell proliferation, lower lactate accumulation and demonstrated better homogeneity of gene expression compared with iPS cells cultured with 4 other media.
Completely free of animal- and human-derived components StemFit® Basic03 is proven to provide highly stable and reproducible culture condition for Induced Pluripotent Stem and Embryonic Stem cells under feeder-free conditions during the reprogramming, expansion and differentiation phases of stem cell culture. StemFit® Basic03 combines high colony forming efficiency with lower than standard media volume consumption to offer cost effective colony expansion when compared to leading competitors.
For a copy of a poster describing this study please visit www.amsbio.com/presentation/stemfit-catapult-poster.pdf
Digital Edition
Lab Asia 31.2 April 2024
April 2024
In This Edition Chromatography Articles - Approaches to troubleshooting an SPE method for the analysis of oligonucleotides (pt i) - High-precision liquid flow processes demand full fluidic c...
View all digital editions
Events
Microbiology Society Annual Conference 2024
Apr 08 2024 Edinburgh 2024
Apr 09 2024 Munich, Germany
Apr 10 2024 Helsinki, Finland
Analytica Anacon India & IndiaLabExpo
Apr 15 2024 Mumbai, India
Apr 16 2024 Moscow, Russia